Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial

Journal of the American Pharmacists Association

Volumn 53, Issue 5, 2013, Pages 520-529

  Svarstad, Bonnie L ^a   Kotchen, Jane Morley ^b   Shireman, Theresa I ^c   Brown, Roger L ^d   Crawford, Stephanie Y ^e   Mount, Jeanine K ^f   Palmer, Pamela A ^g   Vivian, Eva M ^a   Wilson, Dale A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f NORTHEASTERN UNIVERSITY   (United States)

^g Northeastern University ^*

Author keywords

Black patients; Hypertension; Medication adherence; Pharmacy services

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEEDBACK SYSTEM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT INFORMATION; PHARMACIST; PHARMACY TECHNICIAN; PHYSICIAN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADULT; AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLUSTER ANALYSIS; COMMUNITY PHARMACY SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PHARMACISTS' AIDES; PROFESSIONAL ROLE; TIME FACTORS; WISCONSIN;

EID: 84890450224     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.12246     Document Type: Article

References (35)

1. Bailey JE, Wan JY, Tang J, et al. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010;25(6):495-503.
2. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49(1):69-75.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-50.
4. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86(12):1805-8.
5. Shaya FT, Du D, Gbarayor CM, et al. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc. 2009;101(1):34-9.
6. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119(1):70.e9-15.
7. Gerber BS, Cho YI, Arozullah AM, Lee SY. Racial differences in medication adherence: a cross-sectional study of Medicare enrollees. Am J Geriatr Pharmacother. 2010;8(2):136-45.
8. Brown CM, Segal R. Ethnic differences in temporal orientation and its implications for hypertension management. J Health and Soc Behav. 1996;37(4):350-61.
9. Svarstad BL, Kotchen JM, Shireman TI, et al. The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks. Circ Cardiovasc Qual Outcomes. 2009;2(3):264-71.
10. Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44(7):646-57.
11. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):1748-55.
12. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48(5):1104-11.
13. Kicklighter CE, Nelson KM, Humphries TL, Delate T. An evaluation of a clinical pharmacy-directed intervention on blood pressure control. Pharmacy Practice. 2006;4(3):110-6.
14. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22(12):1533-40.
15. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and lowdensity lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71.
16. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857-67.
17. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
18. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164-70.
19. Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44(1):88-96.
20. Chapman RH, Ferrufino CP, Kowal SL, et al. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipidlowering drugs. Int J Clin Pract. 2010;64(2):169-81.
21. van Dalem J, Krass I, Aslani P. Interventions promoting adherence to cardiovascular medicines. Int J Clin Pharm. 2012;34(2):295-311.
22. Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010;23(9):949-55.
23. Carter BL, Doucette WR, Franciscus CL, et al. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy. 2010;30(3):228-35.
24. Wentzlaff DM, Carter BL, Ardery G, et al. Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens (Greenwich). 2011;13(6):431-7.
25. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.
26. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113-24.
27. Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728-40.
28. Raudenbush SW. Statistical analysis and optimal design for cluster randomized trials. Psychological Methods. 1997;2(2):173-85.
29. Xiaofeng L, Spybrook J, Congdon R, et al. Optimal design for multi-level and longitudinal research. Version 1.77. Ann Arbor, MI: University of Michigan; 2006.
30. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford, UK: Oxford Science; 1994.
31. Yang M, Goldstein H, Heath A. Multilevel models for repeated binary outcomes: attitudes and voting over the electoral cycle. J R Statist Soc. 2000;163:49-62.
32. Goldstein H. Multilevel covariance component models. Biometrika. 1986;74(2):430-1.
33. Laird NM. Missing data in longitudinal studies. Statistics in Medicine. 1988;7(1-2):305-15.
34. Hogan JW, Laird NM. Mixture models for the joint distribution of repeated measures and event times. Stat Med. 1997;16(1-3):239-57.
35. Bellg AJ, Borrelli B, Resnick B. et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443-51.